OneAscent Family Office’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$837K Buy
35,073
+1,327
+4% +$32K 0.58% 39
2025
Q4
$817K Buy
33,746
+7,468
+28% +$181K 0.55% 42
2025
Q3
$635K Sell
26,278
-5,527
-17% -$133K 0.52% 51
2025
Q2
$764K Sell
31,805
-3,471
-10% -$82.3K 0.72% 34
2025
Q1
$838K Sell
35,276
-278
-0.8% -$6.57K 0.78% 36
2024
Q4
$833K Buy
+35,554
New +$844K 1.51% 11

Other funds holding IBD

OneAscent Family Office's IBD Position: Q1 2026 in Review

OneAscent Family Office increased its Inspire Corporate Bond ETF (IBD) stake by 3.9% in Q1 2026, buying an estimated $32K and bringing the position to 35,073 shares worth $837K. The position accounts for 0.58% of the portfolio, ranked #39.

OneAscent Family Office first reported a position in IBD in Q4 2024 and has held it in 6 quarters since. The position peaked at $838K in Q1 2025. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

  • OneAscent Family Office held 35,073 shares of Inspire Corporate Bond ETF worth $837K as of Q1 2026.
  • OneAscent Family Office bought 1,327 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $32K.
  • Inspire Corporate Bond ETF made up 0.58% of OneAscent Family Office's portfolio in Q1 2026, its #39 holding.
  • OneAscent Family Office first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 6 quarters since.
  • OneAscent Family Office's Inspire Corporate Bond ETF position peaked at $838K in Q1 2025.
  • 106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on OneAscent Family Office's 13F filing for Q1 2026, filed 21 Apr 2026.